Mutant mouse models of insulin-like growth factor actions in the central nervous system

Neuropeptides

Volumn 36, Issue 2-3, 2002, Pages 209-220

  D'Ercole, Joseph A ^a   Ye, Ping ^a   O'Kusky, John R ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ASTROCYTE; BRAIN GROWTH; BRAIN SIZE; BRAIN WEIGHT; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; GENE OVEREXPRESSION; MICROGLIA; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL LESION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; SYNAPTOGENESIS; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0036551775     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2002.0893     Document Type: Article

References (80)

1. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
2. Insulin-like growth factor-I and central nervous system development
3. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: Distinct actions from those of brain-derived neurotrophic factor
4. Effects of an Igf1 gene null mutation on mouse reproduction
5. Role of insulin-like growth factors in embryonic and postnatal growth
6. Interactions between Bcl-2 and the IGF system control apoptosis in the developing mouse brain
7. Does oligodendrocyte survival depend on axons
8. Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons
9. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal and striatal parvalbumin-containing neurons
10. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice
11. Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes
12. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice
13. Endogenous IGF-1 regulates the neuronal differentiation of adult stem cells
14. Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice
15. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice
16. Mitogenic effect of axolemma-enriched fraction on cultured oligodendrocytes
17. Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition
18. Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner
19. Actions of IGF system proteins from studies of transgenic and gene knockout models
20. Brain growth retardation due to the expression of human insulin-like growth factor binding protein-1 (IGFBP-1) in transgenic mice: An in vivo model for analysis of IGF function in the brain
21. The role of the insulin-like growth factors in the central nervous system
22. Human insulin-like growth factor binding protein-1 (IGFBP-1) transgenic mice: Characterization and insights into the regulation of IGFBP-1 expression
23. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
24. Increased insulin-like growth factor-I (IGF-I) expression during early postnatal development differentially increases neuron number and growth in medullary nuclei of the mouse
25. Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1
26. Neurons and astrocytes influence the development of purified O-2A progenitor cells
27. Fibroblast growth factor is a mitogen for oligodendrocytes in vitro
28. Genetics of Mouse Growth
29. Comparison of the mechanisms of action of insulin and triiodothyronine on the synthesis of cerebroside sulfotransferase in cultures of cells dissociated from brains of embryonic mice
30. The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system
31. Naturally occurring motoneuron cell death in the rat upper respiratory tract motor nuclei: A histological, fast Dil and immunocytochemical study in the hypoglossal nucleus
32. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
33. In vivo effects of insulin-like growth factor-I on the development of sensory pathways: Analysis of the primary somatic sensory cortex (S1) of transgenic mice
34. 3H]2DG study
35. Cell migration to the isocortex in the rat
36. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice
37. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2
38. Insulin-like growth factors and their binding proteins: Biological actions
39. Insulin-like growth factor-I (IGF-I) ameliorates and IGF binding protein-1 (IGFBP-1) exacerbates the effects of undernutrition on brain growth during early postnatal life: Studies in IGF-I and IGFBP-1 transgenic mice
40. Effect of thyroid hormone on brain development, with particular emphasis on glial cells and myelination
41. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor
42. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
43. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds
44. The cellular kinetics of the developing mouse cerebellum. I. The generation cycle, growth fraction and rate of proliferation of the external granule layer
45. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination
46. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
47. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro
48. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors
49. Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development
50. An autoradiographic analysis of histiogenesis in the mouse cerebellum
51. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor
52. Hormonal regulation of insulin-like growth factor binding protein-1 expression and the development of transgenic mouse models to study IGFBP-1 function
53. Expression of human insulin-like binding protein-3 in transgenic mice
54. Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1
55. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell
56. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development
57. The absence of significant postnatal motoneuron death in the brachial and lumbar spinal cord of the rat
58. Time of origin of neurons in the brain stem of the mouse
59. Genetic approaches to the function of insulin like growth factor-binding proteins during rodent development
60. Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family
61. IGF-I is required for normal embryonic growth in mice
62. Glial cell diversification in the rat optic nerve
63. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice
64. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor transgenic mice
65. Overexpression of IGFBP-5 induces severe growth retardation in mice
66. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins
67. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells
68. In situ labeling of apoptotic cell death in cerebral cortex and thalamus of rats during development
69. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus
70. Effects of insulin and insulin-like growth factor (IGF-I) on oligodendrocyte-enriched glial cultures
71. Independent controls of neocortical neuron production and histogenetic cell death
72. Overexpression of Insulin-like Growth Factor Binding Protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle Actin - IGFBP-4 fusion gene induces smooth muscle hypoplasia
73. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: Endocrine changes and effects on body and organ growth
74. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
75. In vivo actions of Insulin-like Growth Factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF Binding Protein-1 (IGFBP-1) transgenic mice
76. Insulin-like growth factor-I influences the initiation of myelination: Studies of the anterior commissure of transgenic mice
77. Insulin-like growth factor I (IGF-I) regulates IGF binding protein-5 gene expression in the brain
78. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury
79. Insulin-like growth factor-I (IGF-I) protects myelination from undernutritional insult: Studies of transgenic mice overexpressing IGF-I in brain
80. In vivo actions of insulin-like growth factor-I (IGF-I) on cerebellum development in transgenic mice: Evidence that IGF-I increases proliferation of granule cell progenitors